top of page

DELIVERING HOPE

​

through 50+ FDA-authorized clinical protocols

Hope Biosciences is proud to partner with academic, university, and independent research organizations across the United States to advance access to and development of our proprietary therapeutics through FDA-authorized research. Hope Bio's cells are and have been at work in the following locations:

download.webp
Methodist_Leading_Medicine_4C_png.png
uthsca.jpg
ucsf logo.png

In the following diseases and conditions:

  • Acute Kidney Injury (AKI)

  • Alzheimer's Disease, early onset

  • Amyotrophic lateral sclerosis (ALS) 

  • Arthritis

  • Ataxia

  • Brain injury, non-traumatic

  • Cerebral Palsy

  • Chronic Inflammatory Polyneuropathy Disorder (CIPD)

  • Congenital Muscular Dystrophy

  • COVID-19

  • Post-COVID-19 Syndrome

  • Crohn's Disease

  • Epilepsy

  • Lupus

  • Multiple Sclerosis (MS)

  • Multiple System Atrophy (MSA)

  • Musculoskeletal pain, chronic

  • Pancreatic cancer

  • Palliative care

  • Parkinson's Disease

  • Primary Lateral Sclerosis (PLS)

  • Rheumatoid Arthritis

  • Spinal Cord Injury

  • Stroke

  • Traumatic Brain Injury (TBI)​

More from our partners:

bottom of page